Delta-Catenin Cleavage by Presenilin and Synaptic Remodeling
Delta-Catenin Cleavage by Presenilin and Synaptic Remodeling
批准号:
6959771
负责人:
QUN LU
金额:
$6.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-01 至 2007-06-30
关键词:
Alzheimer&aposs diseasePC12 cellsamyloid proteinsaspartic endopeptidasescadherinschemical cleavageexcitatory aminoacidfluorescence microscopygene mutationglutamate receptorimmunoprecipitationlaboratory ratneural plasticitypathologic processposttranslational modificationsprotein localizationprotein protein interactionprotein sequenceprotein structure functionproteolysissite directed mutagenesissynapsestissue /cell culturetransfection
中文摘要
描述(由申请人提供):早老素突变与家族性阿尔茨海默病(AD)密切相关。已经确定,早老素表达对于许多不同功能的蛋白质的“γ-分泌酶”加工是必不可少的,包括淀粉样前体蛋白和细胞粘附蛋白钙粘蛋白。本实验室克隆了一种人δ-连环蛋白,它与突触连接处的钙粘蛋白和谷氨酸受体相关,并在谷氨酸刺激后重新分布。我们最近的研究发现,δ-连环蛋白不仅直接结合早老素-1(PS-1),但它也被S-1/γ-分泌酶依赖性活性切割。该RO 3小额资助申请提出了一个研究项目,以测试以下假设:δ-连环蛋白裂解产物与谷氨酸受体复合物相互作用,并促进对兴奋性刺激的突触后反应,如淀粉样蛋白β(AB)肽和N-甲基-D-天冬氨酸,这增加了AD中神经元对兴奋性毒性的脆弱性。为了检验这一假设,Specific Aim 1将采用稳定表达四环素诱导的δ-连环蛋白的PC 12细胞来确定由PS-1/γ-分泌酶依赖性活性产生的δ-连环蛋白切割位点的氨基酸序列。将使用蛋白质测序、定点诱变和cDNA转染来确定δ-连环蛋白切割序列。具体目标2将确定δ-连环蛋白蛋白水解片段在兴奋性刺激(如AB肽和NMDA)的突触后反应中的分布和作用。蛋白质免疫共沉淀和蛋白质印迹将确定δ-连环蛋白片段与谷氨酸受体复合物的相互作用。延时荧光显微成像将确定它们在AB和NMDA刺激后的重新分布。此外,Fura-2比率成像将用于确定δ-连环蛋白片段对细胞内钙水平改变的影响,细胞内钙水平是兴奋性毒性神经元死亡级联反应的中心组分。这个RO 3小额资助项目将导致对PS-1与δ-连环蛋白相互作用调节的突触可塑性机制的新见解。这也将为未来的R 01研究delta-catenin蛋白水解片段在AD发病机制中的作用奠定基础。
英文摘要
DESCRIPTION (provided by applicant): Mutations in presenilins are closely linked to familial Alzheimer's Disease (AD). It is well established that presenilin expression is essential for "y-secretase" processing of many proteins of diverse functions, including the amyloid precursor protein and cell adhesion protein cadherins. This laboratory cloned a human delta-catenin that associates with cadherins and glutamate receptors of synaptic junction, and it redistributes upon glutamate stimulation. Our recent studies found that delta-catenin not only binds directly to presenilin-1 (PS-1), but it is also cleaved by a S-1/y-secretase-dependent activity. This RO3 small grant application proposes a research project to test the hypothesis that delta-catenin cleavage products interact with glutamate receptor complexes and facilitate postsynaptic responses to excitatory stimuli, such as amyloid beta (AB) peptides and N-methyl-D-aspartate, which increase neuronal vulnerability to excitotoxicity in AD. To test this hypothesis, Specific Aim 1 will employ PC12 cells stably expressing a tetracycline-inducible delta-catenin to determine the amino acid sequence of delta-catenin cleavage site generated by PS-1/y-secretase dependent activity. Delta-Catenin cleavage sequence will be determined using protein sequencing, site-directed mutagenesis, and cDNA transfection. Specific Aim 2 will determine the distribution and effects of delta-catenin proteolytic fragments in the postsynaptic responses to excitatory stimuli, such as AB peptides and NMDA. Protein co-immunoprecipitation and Western Blotting will determine the interaction of delta-catenin fragments with glutamate receptor complexes. Time-lapse fluorescent microscopic imaging will determine their redistribution upon AB and NMDA stimulation. In addition, Fura-2 ratiometric imaging will be used to determine the effects of delta-catenin fragments on the alterations of intracellular calcium level, a central component in the excitotoxic neuronal death cascade. This RO3 small grant project will lead to new insights into mechanisms of synaptic plasticity regulated by PS-1 interaction with delta-catenin. It will also lay the foundation for future R01 investigation of the roles of delta-catenin proteolytic fragments in AD pathogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Homeostatic Reset as a New Therapeutic Paradigm for Slow Progression Diseases
-
批准号:10273546
-
项目类别:
-
资助金额:$62.71万
-
财政年份:2021
-
负责人:QUN LU
-
依托单位:
Homeostatic Reset as a New Therapeutic Paradigm for Slow Progression Diseases
-
批准号:10689335
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2021
-
负责人:QUN LU
-
依托单位:
Homeostatic Reset as a New Therapeutic Paradigm for Slow Progression Diseases
-
批准号:10796004
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:QUN LU
-
依托单位:
Homeostatic Reset as a New Therapeutic Paradigm for Slow Progression Diseases
-
批准号:10488273
-
项目类别:
-
资助金额:$61.44万
-
财政年份:2021
-
负责人:QUN LU
-
依托单位:
Rho GTPases and Neuroprotection Model in Cancer Therapy
-
批准号:8232481
-
项目类别:
-
资助金额:$42.16万
-
财政年份:2012
-
负责人:QUN LU
-
依托单位:
Rho GTPases and Neuroprotection Model in Cancer Therapy
-
批准号:8769217
-
项目类别:
-
资助金额:$7.84万
-
财政年份:2012
-
负责人:QUN LU
-
依托单位:
delta-Catenin and Cell-Cell Adhesion in Prostate Cancer
-
批准号:7035153
-
项目类别:
-
资助金额:$18.95万
-
财政年份:2006
-
负责人:QUN LU
-
依托单位:
delta-Catenin and Cell-Cell Adhesion in Prostate Cancer
-
批准号:7186628
-
项目类别:
-
资助金额:$18.4万
-
财政年份:2006
-
负责人:QUN LU
-
依托单位:
delta-Catenin and Cell-Cell Adhesion in Prostate Cancer
-
批准号:8068992
-
项目类别:
-
资助金额:$1.72万
-
财政年份:2006
-
负责人:QUN LU
-
依托单位:
delta-Catenin and Cell-Cell Adhesion in Prostate Cancer
-
批准号:7554661
-
项目类别:
-
资助金额:$18.4万
-
财政年份:2006
-
负责人:QUN LU
-
依托单位:
delta-Catenin and Cell-Cell Adhesion in Prostate Cancer
-
批准号:7345429
-
项目类别:
-
资助金额:$18.4万
-
财政年份:2006
-
负责人:QUN LU
-
依托单位:
Delta-Catenin Cleavage by Presenilin and Synaptic Remodeling
-
批准号:7095974
-
项目类别:
-
资助金额:$5.91万
-
财政年份:2005
-
负责人:QUN LU
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: